Robertson Stephens Wealth Management LLC Buys 8,891 Shares of iShares Biotechnology ETF $IBB

Robertson Stephens Wealth Management LLC boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 363.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 11,334 shares of the financial services provider’s stock after purchasing an additional 8,891 shares during the period. Robertson Stephens Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $1,913,000 as of its most recent filing with the SEC.

Other large investors have also recently modified their holdings of the company. Darwin Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF in the second quarter worth about $25,000. Ashton Thomas Securities LLC purchased a new position in shares of iShares Biotechnology ETF in the third quarter worth about $36,000. Parkside Financial Bank & Trust increased its stake in shares of iShares Biotechnology ETF by 48.6% in the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 87 shares in the last quarter. Close Asset Management Ltd increased its stake in shares of iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after purchasing an additional 70 shares in the last quarter. Finally, Founders Financial Alliance LLC increased its stake in shares of iShares Biotechnology ETF by 605.7% in the third quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock worth $54,000 after purchasing an additional 321 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.8%

IBB opened at $167.27 on Friday. The firm has a 50-day moving average price of $169.84 and a 200-day moving average price of $168.53. iShares Biotechnology ETF has a twelve month low of $116.25 and a twelve month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were paid a $0.1218 dividend. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 annualized dividend and a dividend yield of 0.3%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.